Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Care management for hospice transitions for people with advanced dementia

Official title: ENGAGE-D: Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia

Run by New York University · NCT07182357 · Data updated 2026-11-12

We are testing a dementia care management checklist within home health care to help hospice transitions for people with advanced dementia and support their care partners.

More Alzheimer Disease and Related Dementias trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment96 (estimated)
SponsorNew York University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 13, 2026
Main results expectedDecember 31, 2027
Study endsJuly 31, 2028
Registry record updatedJuly 8, 2026
Trial IDNCT07182357 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Care partners and persons with dementia (moderate to severe) and the home health care professionals who manage hospice transitions, located in New York, NY.

Probably not a fit

Patients or care partners without involvement in hospice transitions or those not using home health care services may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study pilots a dementia care management checklist designed to guide end-of-life care and hospice transitions for people living with dementia and their care partners. It is a single-arm, unblinded feasibility trial embedded in usual home health care management. The study will measure feasibility, acceptability, fidelity, and usability of the checklist, and will also look at hospice enrollment timing and care partner satisfaction. Participants include care partners, persons with dementia, home health care professionals, medical providers, and home health care administrators involved in hospice transitions. The intervention targets improving coordination and communication during hospice transitions within real-world home health care settings.

Why it matters

Potential benefit: If successful, the checklist could streamline hospice transitions and improve satisfaction for care partners and timely hospice enrollment.

How similar studies have gone: Prior work in care management for hospice transitions has shown feasibility in related settings, but this exact dementia-focused checklist in home health care is novel/early-stage.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

Care Partners and PLWD Dyad:

1. Care partners of PLWD who have a diagnosis of moderate to severe dementia.
2. Able to provide informed consent

HHC Professionals:

Care Managers and Field Nurses:

1. Care managers who regularly engage hospice transitions with care partners of PLWD
2. Age 18 or older

Medical Providers:

1. Medical providers (e.g., physicians and nurse practitioners) who refer patients for hospice enrollment.
2. Age 18 or older

HHC Administrators:

1. Home healthcare administrators who work with the Certified Home Health Agency or the Advanced Illness Management Program that refers patients to hospice care
2. Age 18 or older

Exclusion

Care Partner and PLWD Dyad

1. Under age 18
2. Care partners who are caring for PLWD with Mild Cognitive Impairment
3. PLWD with Mild Cognitive Impairment

HHC Professionals: Care Managers, Medical Providers, Administrators

1\. Do not have experience managing hospice transitions for PLWD

Where it's running

  • NYU Rory Meyers College of Nursing and VNS Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.